A Big Tobacco company which invested in a medical cannabis startup will not influence how the smaller firm is run, according to bosses at Oxford Cannabinoid Technologies.
The UK-based firm secured funding earlier this year from Imperial Brands and other businesses including venture capital firm Casa Verde Capital – founded by hip-hop star and renowned cannabis enthusiast Snoop Dogg. The largest partner remains Kingsley Capital Partners, a London-based venture capital firm.
Imperial will be taking a hands-off approach.
OCT managing consultant Fraser Schurer-Lewis said: “Imperial’s investment represents only a small percentage of the total value of OCT. Imperial Brands has no management input or direction into the work of OCT.”
Restricted content. Do you want to read more?
Sign up NOW for 7 days FREE TRIAL and access our briefings section
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector worldwide. Most content is available to subscribers only.
Regulatory report: medical and recreational cannabis – a global overview
CBD-Intel has compiled and classified the regulatory data on medical and recreational cannabis in 50 jurisdictions around the world.
The report, accompanied by a more detailed database, provides an overview of the regulatory situation in the selected countries using maps, and assesses the likelihood that the status quo may change in the future.